Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.


GREY:ALEAF - Post by User

Post by DCFruleson May 17, 2021 4:25pm
181 Views
Post# 33215994

Improved FCF

Improved FCFI agree that Aleafia’s financial performance has been a disaster. However, one minor positive aspect that has gone unnoticed is that Aleafia’s free cash flow (FCF) improved slightly in Q1, although still negative. This is worth mentioning because a stock’s intrinsic value is driven primarily by the anticipated future generation of positive FCFs. Aleafia’s historic FCFs generated in 2020 Q2, Q3 and Q4 and 2021 Q1 are -$16.1M, -$10.4M, -$10.1M and -$7.1M respectively. Although this represents a slight improvement, Aleafia needs to generate positive FCFs and quickly.
Intrinsic value obviously depends on the FCF forecast used. For analysis purposes, I generated 8 FCF forecasts and applied a simplified FCF valuation technique. Aleafia’s intrinsic value per share ranged from $0.24 to $2.36 depending on which FCF forecast one is comfortable with. The concept of FCF, the simplified FCF valuation technique and my eight FCF forecasts, calculations and assumptions are described on my website:
 https://www.npvguide.com/valuing-aleafia-health-inc/

<< Previous
Bullboard Posts
Next >>